Analysts’ Viewpoint
BiPAP device, also known as bi-level positive airway pressure device, is a type of ventilator used in the treatment of sleep apnea and other respiratory disorders. Rise in prevalence of sleep disorders and respiratory diseases is expected to propel the BiPAP devices market size during the forecast period. Increase in awareness about sleep disorders is expected to augment market expansion in the near future.
Auto-adjusting BiPAP are gaining traction, as these help overcome the issues associated with normal BiPAP device. R&D of new technologies is likely to offer lucrative opportunities for vendors in the industry. Key players have adopted various strategies, such as partnerships, collaborations, and new product launches, to increase market share.
BiPAP (bi-level positive airway pressure) device is used in the treatment of sleep apnea and other respiratory disorders. The device provides two types of pressure: expiratory positive airway pressure (EPAP) and inspiratory positive airway pressure (IPAP). The machine mimics patient's natural breathing pattern, enabling them to breathe normally and preventing breathing gaps.
The device is lightweight and portable, and masks for the device are available in various sizes. BiPAP therapy is used to treat sleep apnea, COPD, and other respiratory conditions.
Sleep apnea is a disorder that affects a person's breathing during sleep. It could cause a number of health issues, such as high blood pressure, heart disease, and stroke. BiPAP machine can help prevent the airway from collapsing and enable the user to breathe more easily, making it a popular treatment option for sleep apnea. According to the World Health Organization, sleep apnea is a significant public health concern, affecting around 100 million people globally in 2021.
Rise in awareness about the negative effects of sleep disorders on overall health is another driver of the market. People are becoming more conscious of the importance of good sleep, and are seeking treatment for their sleep disorders, which has led to increase in demand for BiPAP oxygen machines. This, in turn, is likely to bolster BiPAP devices market growth in the next few years.
Rise in awareness about sleep disorders is a major driver of the BiPAP devices industry. People are becoming more aware of the negative effect of sleep disorders on overall health and well-being. Therefore, they are seeking treatment for sleep disorders, which is increasing the demand for BiPAP devices.
Internet has made it easy for people to access information about sleep disorders and to find resources for treatment, which has helped increase awareness about the issue. Government and non-government organizations play a vital role in creating awareness about the importance of good sleep and the hazards of sleep disorders such as sleep apnea. This is encouraging people to seek treatment for their sleep disorders, which in turn is propelling demand for BiPAP devices.
In terms of indication, the sleep apnea segment held the largest BiPAP devices market share in 2021. Increase in prevalence of sleep disorders is likely to drive the segment in the near future. Sleep apnea is a sleep disorder characterized by repetitive interruptions in breathing during sleep.
The market for devices and treatments for sleep apnea is expected to witness significant growth in the next few years, driven by rise in prevalence of sleep apnea and other sleep-related disorders and surge in awareness about the negative effect of untreated sleep disorders.
Technological advancements in sleep apnea devices are driving market development. Manufacturers are introducing new, more advanced, and portable devices, which are designed to improve patient comfort and convenience. For instance, wireless and battery-powered devices are now available, which enable patients to use the devices while traveling or away from an outlet.
Rise in Prevalence of Sleep Apnea among Adults
Based on age group, the adult segment is likely to account for significant share of the global BiPAP devices market during the forecast period. Rise in prevalence of sleep apnea in adults is a major driver of the industry. According to the American Academy of Sleep Medicine, an estimated 22 million people in the U.S. have sleep apnea, and around 84% of them are adults.
North America held the largest share of around 45.0% of global BiPAP devices market demand in 2021. The region is expected to be a highly lucrative market during the forecast period. North America's dominance is ascribed to rise in prevalence of sleep apnea, COPD, asthma, and other respiratory diseases. The U.S. dominated the market in the region in 2031 owing to factors such as presence of leading players and increase in research & development activities.
Asia Pacific is projected to be the fastest growing market for BiPAP devices during the forecast period. This is ascribed to surge in incidence rate of sleep disorders and increase in population.
The global BiPAP devices market is fragmented, with the presence of large number of players. Most of the companies are investing significantly in research & development activities, primarily to develop innovative tests.
Expansion of product portfolio and merger & acquisition are the key strategies adopted by the key players in the global market. Beijing Aeonmed Co., Ltd., BMC Medical Co., Ltd., Drive DeVilbiss Healthcare, Hebei Topson Medical Technology Co., Ltd., Koninklijke Philips N.V, Lowenstein Medical Technology GmbH, React Health, Oventus Medical, ResMed Corp, SEFAM, and Somnetics International, Inc. are the prominent BiPAP devices market players.
Key players has been profiled in the BiPAP devices market report based on parameters such as company overview, strategies, product portfolio, segments, and recent developments.
|
Attribute |
Detail |
|
Size in 2021 |
US$ 299.7 Mn |
|
Forecast (Value) in 2031 |
More than US$ 511.6 Mn |
|
Growth Rate (CAGR) |
5.5% |
|
Forecast Period |
2022–2031 |
|
Historical Data Available for |
2017–2020 |
|
Quantitative Units |
US$ Mn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The global industry was valued at US$ 299.7 Mn in 2021.
It is projected to reach more than US$ 511.6 Mn by 2031.
The CAGR is anticipated to be 5.5% from 2022 to 2031.
Rise in prevalence of sleep apnea & other respiratory diseases and increase in awareness about sleep disorders.
North America is likely to account for significant share during the forecast period.
Beijing Aeonmed Co., Ltd., BMC Medical Co., Ltd., Drive DeVilbiss Healthcare, Hebei Topson Medical Technology Co., Ltd., Koninklijke Philips N.V, Lowenstein Medical Technology GmbH, Oventus Medical, React Health, ResMed Corp, SEFAM, and Somnetics International, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global BiPAP Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global BiPAP Devices Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
4.4.2. Market Volume/Unit Shipments Projections
4.5. Porter’s Five Forces Analysis
5. Key Insights
5.1. Technological Advancements
5.2. Key Industry Events
5.3. Top 3 Players Operating in the Market Space
5.4. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
6. Global BiPAP Devices Market Analysis and Forecast, by Indication
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Indication, 2017–2031
6.3.1. Chronic Obstructive Pulmonary Disease
6.3.2. Sleep Apnea
6.3.3. Asthma
6.3.4. Others
6.4. Market Attractiveness Analysis, by Indication
7. Global BiPAP Devices Market Analysis and Forecast, by Age Group
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Age Group, 2017–2031
7.3.1. Adult
7.3.2. Pediatric
7.4. Market Attractiveness Analysis, by Age Group
8. Global BiPAP Devices Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Sleep Facilities
8.3.3. Homecare
8.3.4. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global BiPAP Devices Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America BiPAP Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Indication, 2017–2031
10.2.1. Chronic Obstructive Pulmonary Disease
10.2.2. Sleep Apnea
10.2.3. Asthma
10.2.4. Others
10.3. Market Value Forecast, by Age Group, 2017–2031
10.3.1. Adult
10.3.2. Pediatric
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Sleep Facilities
10.4.3. Homecare
10.4.4. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Indication
10.6.2. By Age Group
10.6.3. By End-user
10.6.4. By Country
11. Europe BiPAP Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Indication, 2017–2031
11.2.1. Chronic Obstructive Pulmonary Disease
11.2.2. Sleep Apnea
11.2.3. Asthma
11.2.4. Others
11.3. Market Value Forecast, by Age Group, 2017–2031
11.3.1. Adult
11.3.2. Pediatric
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Sleep Facilities
11.4.3. Homecare
11.4.4. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Indication
11.6.2. By Age Group
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific BiPAP Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Indication, 2017–2031
12.2.1. Chronic Obstructive Pulmonary Disease
12.2.2. Sleep Apnea
12.2.3. Asthma
12.2.4. Others
12.3. Market Value Forecast, by Age Group, 2017–2031
12.3.1. Adult
12.3.2. Pediatric
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Sleep Facilities
12.4.3. Homecare
12.4.4. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Indication
12.6.2. By Age Group
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America BiPAP Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Indication, 2017–2031
13.2.1. Chronic Obstructive Pulmonary Disease
13.2.2. Sleep Apnea
13.2.3. Asthma
13.2.4. Others
13.3. Market Value Forecast, by Age Group, 2017–2031
13.3.1. Adult
13.3.2. Pediatric
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Sleep Facilities
13.4.3. Homecare
13.4.4. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Indication
13.6.2. By Age Group
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa BiPAP Devices Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Indication, 2017–2031
14.2.1. Chronic Obstructive Pulmonary Disease
14.2.2. Sleep Apnea
14.2.3. Asthma
14.2.4. Others
14.3. Market Value Forecast, by Age Group, 2017–2031
14.3.1. Adult
14.3.2. Pediatric
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Sleep Facilities
14.4.3. Homecare
14.4.4. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Indication
14.6.2. By Age Group
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2021
15.3. Company Profiles
15.3.1. Beijing Aeonmed Co., Ltd.
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Indication Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. BMC Medical Co., Ltd.
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Indication Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Drive DeVilbiss Healthcare
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Indication Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Hebei Topson Medical Technology Co., Ltd.
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Indication Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Koninklijke Philips N.V.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Indication Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.6. Löwenstein Medical Technology GmbH
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Indication Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.7. React Health
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Indication Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.8. ResMed Corp.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Indication Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.9. SEFAM
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Indication Portfolio
15.3.9.3. Financial Overview
15.3.10. Somnetics International, Inc.
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Indication Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.11. Oventus Medical
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Indication Portfolio
15.3.11.3. Financial Overview
15.3.11.4. SWOT Analysis
List of Tables
Table 01: Global BiPAP Devices Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 02: Global BiPAP Devices Market Value (US$ Mn) Forecast, by Age Group, 2017–2031
Table 03: Global BiPAP Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global BiPAP Devices Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America BiPAP Devices Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America BiPAP Devices Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 07: North America BiPAP Devices Market Value (US$ Mn) Forecast, by Age Group, 2017–2031
Table 08: North America BiPAP Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Europe BiPAP Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe BiPAP Devices Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 11: Europe BiPAP Devices Market Value (US$ Mn) Forecast, by Age Group, 2017–2031
Table 12: Europe BiPAP Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Asia Pacific BiPAP Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific BiPAP Devices Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 15: Asia Pacific BiPAP Devices Market Value (US$ Mn) Forecast, by Age Group, 2017–2031
Table 16: Asia Pacific BiPAP Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Latin America BiPAP Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America BiPAP Devices Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 19: Latin America BiPAP Devices Market Value (US$ Mn) Forecast, by Age Group, 2017–2031
Table 20: Latin America BiPAP Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Middle East & Africa BiPAP Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa BiPAP Devices Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 23: Middle East & Africa BiPAP Devices Market Value (US$ Mn) Forecast, by Age Group, 2017–2031
Table 24: Middle East & Africa BiPAP Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global BiPAP Devices Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global BiPAP Devices Market Value Share, by Indication (2021)
Figure 03: Global BiPAP Devices Market Value Share, by End-user (2021)
Figure 04: Global BiPAP Devices Market Value Share, by Age Group (2021)
Figure 05: Global BiPAP Devices Market Value Share, by Region (2021)
Figure 06: Global BiPAP Devices Market Value Share Analysis, by Indication, 2021 and 2031
Figure 07: Global BiPAP Devices Market Attractiveness Analysis, by Indication, 2022–2031
Figure 08: Global BiPAP Devices Market Value Share Analysis, by Age Group, 2021 and 2031
Figure 09: Global BiPAP Devices Market Attractiveness Analysis, by Age Group, 2022–2031
Figure 10: Global BiPAP Devices Market Value Share Analysis, by End-user, 2021 and 2031
Figure 11: Global BiPAP Devices Market Attractiveness Analysis, by End-user, 2022–2031
Figure 12: Global BiPAP Devices Market Value Share Analysis, by Region, 2021 and 2031
Figure 13: Global BiPAP Devices Market Attractiveness Analysis, by Region, 2022-2031
Figure 14: North America BiPAP Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 15: North America BiPAP Devices Market Value Share (%), by Country, 2021 and 2031
Figure 16: North America BiPAP Devices Market Attractiveness Analysis, by Country, 2022–2031
Figure 17: North America BiPAP Devices Market Value Share Analysis, by Indication, 2021 and 2031
Figure 18: North America BiPAP Devices Market Attractiveness Analysis, by Indication, 2022–2031
Figure 19: North America BiPAP Devices Market Value Share Analysis, by Age Group, 2021 and 2031
Figure 20: North America BiPAP Devices Market Attractiveness Analysis, by Age Group, 2022–2031
Figure 21: North America BiPAP Devices Market Value Share Analysis, by End-user, 2021 and 2031
Figure 22: North America BiPAP Devices Market Attractiveness Analysis, by End-user, 2022–2031
Figure 23: Europe BiPAP Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 24: Europe BiPAP Devices Market Value Share (%), by Country/Sub-region, 2021 and 2031
Figure 25: Europe BiPAP Devices Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 26: Europe BiPAP Devices Market Value Share Analysis, by Indication, 2021 and 2031
Figure 27: Europe BiPAP Devices Market Attractiveness Analysis, by Indication, 2022–2031
Figure 28: Europe BiPAP Devices Market Value Share Analysis, by Age Group, 2021 and 2031
Figure 29: Europe BiPAP Devices Market Attractiveness Analysis, by Age Group, 2022–2031
Figure 30: Europe BiPAP Devices Market Value Share Analysis, by End-user, 2021 and 2031
Figure 31: Europe BiPAP Devices Market Attractiveness Analysis, by End-user, 2022–2031
Figure 32: Asia Pacific BiPAP Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 33: Asia Pacific BiPAP Devices Market Value Share (%), by Country/Sub-region, 2021 and 2031
Figure 34: Asia Pacific BiPAP Devices Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 35: Asia Pacific BiPAP Devices Market Value Share Analysis, by Indication, 2021 and 2031
Figure 36: Asia Pacific BiPAP Devices Market Attractiveness Analysis, by Indication, 2022–2031
Figure 37: Asia Pacific BiPAP Devices Market Value Share Analysis, by Age Group, 2021 and 2031
Figure 38: Asia Pacific BiPAP Devices Market Attractiveness Analysis, by Age Group, 2022–2031
Figure 39: Asia Pacific BiPAP Devices Market Value Share Analysis, by End-user, 2021 and 2031
Figure 40: Asia Pacific BiPAP Devices Market Attractiveness Analysis, by End-user, 2022–2031
Figure 41: Latin America BiPAP Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 42: Latin America BiPAP Devices Market Value Share (%), by Country/Sub-region, 2021 and 2031
Figure 43: Latin America BiPAP Devices Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 44: Latin America BiPAP Devices Market Value Share Analysis, by Indication, 2021 and 2031
Figure 45: Latin America BiPAP Devices Market Attractiveness Analysis, by Indication, 2022–2031
Figure 46: Latin America BiPAP Devices Market Value Share Analysis, by Age Group, 2021 and 2031
Figure 47: Latin America BiPAP Devices Market Attractiveness Analysis, by Age Group, 2022–2031
Figure 48: Latin America BiPAP Devices Market Value Share Analysis, by End-user, 2021 and 2031
Figure 49: Latin America BiPAP Devices Market Attractiveness Analysis, by End-user, 2022–2031
Figure 50: Middle East & Africa BiPAP Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 51: Middle East & Africa BiPAP Devices Market Value Share (%), by Country/Sub-region, 2021 and 2031
Figure 52: Middle East & Africa BiPAP Devices Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 53: Middle East & Africa BiPAP Devices Market Value Share Analysis, by Indication, 2021 and 2031
Figure 54: Middle East & Africa BiPAP Devices Market Attractiveness Analysis, by Indication, 2022–2031
Figure 55: Middle East & Africa BiPAP Devices Market Value Share Analysis, by Age Group, 2021 and 2031
Figure 56: Middle East & Africa BiPAP Devices Market Attractiveness Analysis, by Age Group, 2022–2031
Figure 57: Middle East & Africa BiPAP Devices Market Value Share Analysis, by End-user, 2021 and 2031
Figure 58: Middle East & Africa BiPAP Devices Market Attractiveness Analysis, by End-user, 2022–2031
Figure 59: Global BiPAP Devices Market Share Analysis, by Company, 2021
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
BiPAP Devices Market
